CD34 and myelodysplastic syndrome: Yue et al. [38] measured the expression of CD123 on CD34+/CD38− cells in the bone marrow of Myelodysplastic Syndrome (MDS) patients and detected overexpression in 48% of cases, which was correlated with the percentage of bone marrow CD34+ blasts.